These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30697194)

  • 1. Protein
    Ferron M; Denis M; Persello A; Rathagirishnan R; Lauzier B
    Front Endocrinol (Lausanne); 2018; 9():819. PubMed ID: 30697194
    [No Abstract]   [Full Text] [Related]  

  • 2. O-GlcNAcylation, enemy or ally during cardiac hypertrophy development?
    Mailleux F; Gélinas R; Beauloye C; Horman S; Bertrand L
    Biochim Biophys Acta; 2016 Dec; 1862(12):2232-2243. PubMed ID: 27544701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein O-GlcNAcylation in the heart.
    Ng YH; Okolo CA; Erickson JR; Baldi JC; Jones PP
    Acta Physiol (Oxf); 2021 Sep; 233(1):e13696. PubMed ID: 34057811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein O-GlcNAcylation: A critical regulator of the cellular response to stress.
    Chatham JC; Marchase RB
    Curr Signal Transduct Ther; 2010 Jan; 5(1):49-59. PubMed ID: 22308107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreasing O-GlcNAcylation affects the malignant transformation of MCF-7 cells via Hsp27 expression and its O-GlcNAc modification.
    Netsirisawan P; Chaiyawat P; Chokchaichamnankit D; Lirdprapamongkol K; Srisomsap C; Svasti J; Champattanachai V
    Oncol Rep; 2018 Oct; 40(4):2193-2205. PubMed ID: 30106436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. O-GlcNAcylation Negatively Regulates Cardiomyogenic Fate in Adult Mouse Cardiac Mesenchymal Stromal Cells.
    Zafir A; Bradley JA; Long BW; Muthusamy S; Li Q; Hill BG; Wysoczynski M; Prabhu SD; Bhatnagar A; Bolli R; Jones SP
    PLoS One; 2015; 10(11):e0142939. PubMed ID: 26565625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. O-GlcNAc modification affects the ATM-mediated DNA damage response.
    Miura Y; Sakurai Y; Endo T
    Biochim Biophys Acta; 2012 Oct; 1820(10):1678-85. PubMed ID: 22759405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of ALDH2 by O-GlcNAcylation contributes to the hyperglycemic exacerbation of myocardial ischemia/reperfusion injury.
    Liu B; Wang J; Li M; Yuan Q; Xue M; Xu F; Chen Y
    Oncotarget; 2017 Mar; 8(12):19413-19426. PubMed ID: 28038474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac O-GlcNAc signaling is increased in hypertrophy and heart failure.
    Lunde IG; Aronsen JM; Kvaløy H; Qvigstad E; Sjaastad I; Tønnessen T; Christensen G; Grønning-Wang LM; Carlson CR
    Physiol Genomics; 2012 Feb; 44(2):162-72. PubMed ID: 22128088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. O-GlcNAcylation and Inflammation: A Vast Territory to Explore.
    Baudoin L; Issad T
    Front Endocrinol (Lausanne); 2014; 5():235. PubMed ID: 25620956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. O-GlcNAcylation under hypoxic conditions and its effects on the blood-retinal barrier in diabetic retinopathy.
    Xu C; Liu G; Liu X; Wang F
    Int J Mol Med; 2014 Mar; 33(3):624-32. PubMed ID: 24366041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. O-GlcNAcylation is a key modulator of skeletal muscle sarcomeric morphometry associated to modulation of protein-protein interactions.
    Lambert M; Richard E; Duban-Deweer S; Krzewinski F; Deracinois B; Dupont E; Bastide B; Cieniewski-Bernard C
    Biochim Biophys Acta; 2016 Sep; 1860(9):2017-30. PubMed ID: 27301331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of O-GlcNAcylation in the Skeletal Muscle Physiology and Physiopathology: Focus on Muscle Metabolism.
    Lambert M; Bastide B; Cieniewski-Bernard C
    Front Endocrinol (Lausanne); 2018; 9():578. PubMed ID: 30459708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Protein O-GlcNAcylation and regulation of cell signalling: involvement in pathophysiology].
    Issad T; Pagesy P
    Biol Aujourdhui; 2014; 208(2):109-17. PubMed ID: 25190571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperglycaemic conditions perturb mouse oocyte in vitro developmental competence via beta-O-linked glycosylation of heat shock protein 90.
    Frank LA; Sutton-McDowall ML; Brown HM; Russell DL; Gilchrist RB; Thompson JG
    Hum Reprod; 2014 Jun; 29(6):1292-303. PubMed ID: 24713123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of O-GlcNAc in chronic diseases of aging.
    Banerjee PS; Lagerlöf O; Hart GW
    Mol Aspects Med; 2016 Oct; 51():1-15. PubMed ID: 27259471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of O-GlcNAcylation in nutritional sensing, insulin resistance and in mediating the benefits of exercise.
    Myslicki JP; Belke DD; Shearer J
    Appl Physiol Nutr Metab; 2014 Nov; 39(11):1205-13. PubMed ID: 25203141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Sulfur-Linked Analogue of O-GlcNAc (S-GlcNAc) Is an Enzymatically Stable and Reasonable Structural Surrogate for O-GlcNAc at the Peptide and Protein Levels.
    De Leon CA; Levine PM; Craven TW; Pratt MR
    Biochemistry; 2017 Jul; 56(27):3507-3517. PubMed ID: 28627871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. O-GlcNAc transferase inhibits KSHV propagation and modifies replication relevant viral proteins as detected by systematic O-GlcNAcylation analysis.
    Jochmann R; Pfannstiel J; Chudasama P; Kuhn E; Konrad A; Stürzl M
    Glycobiology; 2013 Oct; 23(10):1114-30. PubMed ID: 23580777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. O-GlcNAcylation of cardiac Nav1.5 contributes to the development of arrhythmias in diabetic hearts.
    Yu P; Hu L; Xie J; Chen S; Huang L; Xu Z; Liu X; Zhou Q; Yuan P; Yan X; Jin J; Shen Y; Zhu W; Fu L; Chen Q; Yu J; Hu J; Cao Q; Wan R; Hong K
    Int J Cardiol; 2018 Jun; 260():74-81. PubMed ID: 29530619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.